Canada markets close in 2 hours 33 minutes

XORTX Therapeutics Inc. (XRX.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
3.2000-0.1000 (-3.03%)
As of 1:26PM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 534.79M
Enterprise Value 334.33M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)10.48
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-10.57

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 3108.22%
S&P500 52-Week Change 331.55%
52 Week High 39.9790
52 Week Low 31.1153
50-Day Moving Average 36.2402
200-Day Moving Average 33.3941

Share Statistics

Avg Vol (3 month) 3101.54k
Avg Vol (10 day) 3195.22k
Shares Outstanding 512.29M
Implied Shares Outstanding 6N/A
Float 88.95M
% Held by Insiders 16.85%
% Held by Institutions 110.89%
Shares Short (Sep. 14, 2021) 489.31k
Short Ratio (Sep. 14, 2021) 40.63
Short % of Float (Sep. 14, 2021) 4N/A
Short % of Shares Outstanding (Sep. 14, 2021) 40.95%
Shares Short (prior month Aug. 12, 2021) 432.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Sep. 22, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.34%
Return on Equity (ttm)-122.81%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-3.27M
Diluted EPS (ttm)-0.4160
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.15M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.77
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-579.96k
Levered Free Cash Flow (ttm)2.71M